--- title: "Embecta (EMBC) stock listing, news and investor profile" url: "https://aibio.space/companies/embecta/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Embecta Corp. (NASDAQ: EMBC), United States. Listing facts, related biotech companies and news on aibio.space." --- EMBC Embecta Corp. NASDAQ · United States # Embecta (EMBC) news Embecta Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker EMBC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Embecta news We have not published a story on Embecta yet. When there is news, it will appear here. ## Embecta at a glance - **Ticker**: EMBC - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $214.7 million ### Related companies - [LENSAR](https://aibio.space/companies/lensar/) NASDAQ: LNSR - [PHIBRO ANIMAL HEALTH CORP](https://aibio.space/companies/phibro-animal-health/) NASDAQ: PAHC - [Schrodinger](https://aibio.space/companies/schrodinger/) NASDAQ: SDGR - [LAKELAND INDUSTRIES INC](https://aibio.space/companies/lakeland-industries/) NASDAQ: LAKE - [MARAVAI LIFESCIENCES HOLDINGS, INC.](https://aibio.space/companies/maravai-lifesciences/) NASDAQ: MRVI - [IM Cannabis](https://aibio.space/companies/im-cannabis/) NASDAQ: IMCC - [Outset Medical](https://aibio.space/companies/outset-medical/) NASDAQ: OM - [AIBOTICS, INC.](https://aibio.space/companies/aibotics/) OTC: AIBT ### Also on NASDAQ - [Sight Sciences](https://aibio.space/companies/sight-sciences/) SGHT - [EXAGEN INC.](https://aibio.space/companies/exagen/) XGN - [SkinHealth Systems](https://aibio.space/companies/skinhealth-systems/) SKIN - [InMed Pharmaceuticals](https://aibio.space/companies/inmed-pharmaceuticals/) INM - [Indaptus Therapeutics](https://aibio.space/companies/indaptus-therapeutics/) INDP - [Greenland Mines](https://aibio.space/companies/greenland-mines/) GRML ## Embecta annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Revenue | [$1.08 billion](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | [$1.12 billion](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | | Research and development | [$37.3 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | [$78.8 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | | Net income (loss) | [$95.4 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | [$78.3 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | | Cash from operations | [$191.7 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | [$35.7 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | | Cash and equivalents | [$225.5 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278926000033/) | [$267.5 million](https://www.sec.gov/Archives/edgar/data/1872789/000187278925000036/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $214.7 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Embecta What is the ticker symbol of Embecta? Embecta Corp. trades under the ticker EMBC on NASDAQ. Where is Embecta listed? Embecta Corp. is listed on NASDAQ. Which country or territory is Embecta listed under? Our directory records Embecta Corp. under United States. Does aibio.space cover Embecta? aibio.space lists Embecta Corp. among 2,820 public biotech companies and publishes its news here as stories appear. What was Embecta's revenue last year? $1.08 billion for the fiscal year ended Sep 30, 2025, as reported to the SEC. Is Embecta profitable? Embecta Corp. reported net income of $95.4 million for the fiscal year ended Sep 30, 2025, and generated $191.7 million of cash from operations, per its annual report to the SEC. How much does Embecta spend on research and development? $37.3 million in the fiscal year ended Sep 30, 2025, per its annual report. How much cash does Embecta have? $214.7 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: Embecta Members talk about Embecta (EMBC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Embecta, newest first. Each line links the filing it comes from. 1. 2026-08-07 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1872789/000187278926000033/embc-20260630.htm) 2. 2026-05-15 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/ss6329586_ex9901.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:EMBC on TradingView](https://www.tradingview.com/symbols/NASDAQ-EMBC/). ## Listing details Embecta Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker EMBC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Embecta Corp. - **Ticker**: EMBC - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/embecta/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Embecta (EMBC) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/embecta/